ARIES SARS-CoV-2 Assay, REF: 50-10047
FDA Recall Z-0134-2023 · Posted 2022-10-26
Advertisement
Recalling FirmLuminex Corporation
Recall StatusOpen, Classified
Product CodeQJR
Date Initiated2022-09-14
Product Quantity5,141 (24 Cassettes)
Reason for Recall
A part defect with the wash 1 syringe of an SARS-CoV-2 assay could lead to incomplete extraction thereby producing an invalid or false negative assay result.
Firm Action
On 09/14/22, recall notices were emailed to customers who were asked to do the following:
1. Cease all use, and isolate or quarantine affected devices pending disposal.
2. If affected devices are identified, contact the recalling firm at [email protected] to arrange for replacement and confirm the disposal of any remaining kits in your inventory per the package insert disposal guidelines.
3. Perform a retrospective review of results obtained using the affected SARS-CoV-2 Assay. If you suspect that you have encountered a false negative result
with a patient sample, please contact the recalling firm at [email protected].
4. Distribute the notification to any individuals within your organization who need to be made aware of this recall.
5. If affected devices were further distributed, notify your customers of this recall.
6. Please complete and return the Acknowledgement & Receipt Form.
7. For those with complaints, questions, or concerns, please contact Global Technical
Support Services at 1-877-785-2323 (U.S. and Canada) or +1-512-381 -4397 (Outside U.S. and Canada).
On 12/05/22, additional recall notices were sent to customers notifying them that two additional lots were impacted.
Root Cause
Packaging process control
Distribution Pattern
Distribution US nationwide, Indonesia, and Hong Kong.
Official Source
View FDA Recall →Source: FDA Enforcement Report / Recall database. Always confirm against the official FDA record.
Advertisement